Table 2 Expression of ER, PR and HER2 in cases and distribution of breast cancer molecular subtypes
From: Breast cancer in togolese women: immunohistochemistry subtypes
Variables | Number of patients (%) |
|---|---|
Estrogen receptor status | |
Positive | 64 (54.7) |
Negative | 53 (45.3) |
Progesterone receptor status | |
Positive | 48 (41) |
Negative | 69 (59) |
HER2 Status | |
Positive | 18 (15.4) |
Negative | 99 (84.6) |
Molecular subtype | |
Luminal A | 36 (30.8) |
Luminal B | 28 (23.9) |
Triple Negative | 44 (37.6) |
HER2 enriched | 9 (7.7) |